1887

Abstract

The severity of disease caused in humans by H5N1 influenza viruses remains unexplained. The NS gene of Hong Kong H5N1/97 viruses was shown to contribute to high pathogenicity of reassortants in a pig model. However, the molecular pathogenesis and host immune response underlying this phenomenon remain unclear. Here, in a mouse model, H1N1 A/Puerto Rico/8/34 (PR/8) reassortants that contained the H5N1/97 NS gene, the H5N1/01 NS gene, or an altered H5N1/97 NS gene encoding a Glu→Asp substitution in NS1 was studied. The pathogenicity of reassortant viruses, the induction of cytokines and chemokine CXCL1 (KC) in the lungs and specific B- and T-cell responses was characterized. In mice infected with reassortant virus containing the H5N1/97 NS gene, the mouse lethal dose (50 %) and lung virus titres were similar to those of PR/8, which is highly pathogenic to mice. This reassortant virus required two more days than PR/8 to be cleared from the lungs of infected mice. Reassortants containing the altered H5N1/97 NS gene or the H5N1/01 NS gene demonstrated attenuated pathogenicity and lower lung titres in mice. Specific B- and T-cell responses were consistent with viral pathogenicity and did not explain the delayed clearance of the H5N1/97 NS reassortant. The reassortant induced elevated pulmonary concentrations of the inflammatory cytokines IL1, IL1, IL6, IFN- and chemokine KC, and decreased concentrations of the anti-inflammatory cytokine IL10. This cytokine imbalance is reminiscent of the clinical findings in two humans who died of H5N1/97 infection and may explain the unusual severity of the disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80663-0
2005-04-01
2020-08-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/4/vir861121.html?itemId=/content/journal/jgv/10.1099/vir.0.80663-0&mimeType=html&fmt=ahah

References

  1. Altman J. D., Moss P. A., Goulder P. J., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M. 1996; Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94–96 [CrossRef]
    [Google Scholar]
  2. Basler C. F., Reid A. H., Dybing J. K. 9 other authors 2001; Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A 98:2746–2751 [CrossRef]
    [Google Scholar]
  3. Belz G. T., Xie W., Altman J. D., Doherty P. C. 2000; A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge. J Virol 74:3486–3493 [CrossRef]
    [Google Scholar]
  4. Belz G. T., Xie W., Doherty P. C. 2001; Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J Immunol 166:4627–4633 [CrossRef]
    [Google Scholar]
  5. Cheung C. Y., Poon L. L. M., Lau A. S., Luk W., Lau Y. L., Shortridge K. F., Gordon S., Guan Y., Peiris J. S. M. 2002; Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360:1831–1837 [CrossRef]
    [Google Scholar]
  6. Claas E. C., Osterhaus A. D., van Beek R., De Jong J. C., Rimmelzwaan G. F., Senne D. A., Krauss S., Shortridge K. F., Webster R. G. 1998; Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472–477 [CrossRef]
    [Google Scholar]
  7. Doherty P. C., Allan W., Eichelberger W., Carding S. R. 1992; Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 10:123–151 [CrossRef]
    [Google Scholar]
  8. Fisman D. N. 2000; Hemophagocytic syndromes and infection. Emerg Infect Dis 6:601–608 [CrossRef]
    [Google Scholar]
  9. Flynn K. J., Belz G. T., Altman J. D., Ahmed R., Woodland D. L., Doherty P. C. 1998; Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683–691 [CrossRef]
    [Google Scholar]
  10. Garcia-Sastre A. 2001; Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375–384 [CrossRef]
    [Google Scholar]
  11. Garcia-Sastre A. 2002; Mechanisms of inhibition of the host interferon α / β -mediated antiviral response by viruses. Microbes Infect 4:647–655 [CrossRef]
    [Google Scholar]
  12. Garcia-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T. 1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330 [CrossRef]
    [Google Scholar]
  13. Geiss G. K., Salvatore M., Tumpey T. M. 8 other authors 2002; Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution for pandemic influenza. Proc Natl Acad Sci U S A 99:10736–10741 [CrossRef]
    [Google Scholar]
  14. Guan Y., Peiris J. S. M., Lipatov A. S., Ellis T. M., Dyrting K. C., Krauss S., Zhang L. J., Webster R. G., Shortridge K. F. 2002; Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A 99:8950–8955 [CrossRef]
    [Google Scholar]
  15. Guan Y., Poon L. L. M., Cheung C. Y. 10 other authors 2004; H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 101:8156–8161 [CrossRef]
    [Google Scholar]
  16. Hamilton T. A., Ohmori Y., Tebo J. 2002; Regulation of chemokine expression by anti-inflammatory cytokines. Immunol Res 25:229–245 [CrossRef]
    [Google Scholar]
  17. Hayden F. G., Fritz R. S., Lobo M., Alvord W. G., Strober W., Straus S. E. 1998; Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.. J Clin Invest 101:643–649 [CrossRef]
    [Google Scholar]
  18. Headley A. S., Tolley E., Meduri G. U. 1997; Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111:1306–1321 [CrossRef]
    [Google Scholar]
  19. Hennet T., Ziltener H. J., Frei K., Peterhans E. 1992; A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149:932–939
    [Google Scholar]
  20. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R. G. 2000; A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113 [CrossRef]
    [Google Scholar]
  21. Hoffmann E., Stech J., Guan Y., Webster R. G., Perez D. R. 2001; Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275–2289 [CrossRef]
    [Google Scholar]
  22. Hoffmann E., Krauss S., Perez D., Webby R., Webster R. G. 2002; Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20:3165–3170 [CrossRef]
    [Google Scholar]
  23. Hou S., Hyland L., Ryan K. W., Portner A., Doherty P. C. 1994; Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369:652–654 [CrossRef]
    [Google Scholar]
  24. Kaiser L., Fritz R. S., Straus S. E., Gubareva L., Hayden F. G. 2001; Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64:262–268 [CrossRef]
    [Google Scholar]
  25. Krug R. M., Yuan W., Noah D. L., Latham A. G. 2003; Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181–189 [CrossRef]
    [Google Scholar]
  26. Lipatov A. S., Krauss S., Guan Y., Peiris M., Rehg J. E., Perez D. R., Webster R. G. 2003; Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol 77:3816–3823 [CrossRef]
    [Google Scholar]
  27. Monteiro J. M., Harvey C., Trinchieri G. 1998; Role of interleukin-12 in primary influenza virus infection. J Virol 72:4825–4831
    [Google Scholar]
  28. Moore K. W., de Waal Malefyt R., Coffman R. L., O'Garra A. 2001; Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765 [CrossRef]
    [Google Scholar]
  29. Reed L. J., Muench H. 1938; A simple method for estimating fifty percent endpoints. Am J Hyg 27:493–497
    [Google Scholar]
  30. Sangster M. Y., Topham D. J., D'Costa S., Cardin R. D., Marion T. N., Myers L. K., Doherty P. C. 2000; Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164:1820–1828 [CrossRef]
    [Google Scholar]
  31. Sarawar S. R., Doherty P. C. 1994; Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol 68:3112–3119
    [Google Scholar]
  32. Seo S. H., Webster R. G. 2002; Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 76:1071–1076 [CrossRef]
    [Google Scholar]
  33. Seo S. H., Goloubeva O., Webby R., Webster R. G. 2001; Characterization of a porcine lung epithelial cell line suitable for influenza virus studies. J Virol 75:9517–9525 [CrossRef]
    [Google Scholar]
  34. Seo S. H., Hoffmann E., Webster R. G. 2002; Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8:950–954 [CrossRef]
    [Google Scholar]
  35. Skoner D. P., Gentile D. A., Patel A., Doyle W. J. 1999; Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 180:10–14 [CrossRef]
    [Google Scholar]
  36. Subbarao K., Klimov A., Katz J. 13 other authors 1998; Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393–396 [CrossRef]
    [Google Scholar]
  37. Talon J., Salvatore M., O'Neill R. E., Nakaya Y., Zheng H., Muster T., Garcia-Sastre A., Palese P. 2000; Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97:4309–4314 [CrossRef]
    [Google Scholar]
  38. To K. F., Chan P. K., Chan K. F. 9 other authors 2001; Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63:242–246 [CrossRef]
    [Google Scholar]
  39. Townsend A. R., Rothbard J., Gotch F. M., Bahadur G., Wraith D., McMichael A. J. 1986; The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968 [CrossRef]
    [Google Scholar]
  40. Tumpey T. M., Lu X., Morken T., Zaki S. R., Katz J. M. 2000; Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 74:6105–6116 [CrossRef]
    [Google Scholar]
  41. Yuen K. Y., Chan P. K. S., Peiris M. 8 other authors 1998; Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467–471 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80663-0
Loading
/content/journal/jgv/10.1099/vir.0.80663-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error